Skip to main content
Board of Directors
A word from the CEO
The AGIR program
Platform of Expertise
News & events
To answer health and environmental challenges
Next generation anti-infectives
Active ingredients of natural origin
DEINOVE announces its financial calendar for 2019
DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses a disruptive approach to...
Deinove is preparing initiation of Phase II for DNV3837 in Clostridium difficile infections, with a key partner
The test design has been improved for a better assessment of DNV3837 effectiveness in treating...
More press releases
Antibiotic resistance, a global health challenge
The development of antibiotic resistance is, according to international organizations and governments, one of the major health challenges of the 21st century
In the Medias
La Tribune | La biotech Deinove entre en phase clinique sur un antibiotique novateur
La Biotech.eu | How to Make Industrial Biotech Pay
Making enough money to survive long enough to get a product to market can be tough for any biotech, but even more so for companies...
More press coverage